Trial · NCT03457701
Results by group106
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 106
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Fractional Oral Iron Absorption Following Treatment With Daprodustat and rhEPO | Daprodustat | 20.64 | 95% Confidence Interval 10.96 to 30.32 | Percentage (%) of iron absorbed | |
| Percentage of Fractional Oral Iron Absorption Following Treatment With Daprodustat and rhEPO | rhEPO | 20.62 | 95% Confidence Interval 10.95 to 30.30 | Percentage (%) of iron absorbed | |
| Periods 1 and 2: Change From Baseline in Serum Iron Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 14 | -1.5 | Standard Deviation 6.72 | Micromoles per liter (umol/L) |
| Periods 1 and 2: Change From Baseline in Serum Iron Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 14 | 1.7 | Standard Deviation 4.93 | Micromoles per liter (umol/L) |
| Periods 1 and 2: Change From Baseline in Serum Iron Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 28 | 2.5 | Standard Deviation 8.96 | Micromoles per liter (umol/L) |
| Periods 1 and 2: Change From Baseline in Serum Iron Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 28 | 3.3 | Standard Deviation 5.47 | Micromoles per liter (umol/L) |
| Periods 1 and 2: Change From Baseline in Serum Iron Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 14 | -1.3 | Standard Deviation 4.93 | Micromoles per liter (umol/L) |
| Periods 1 and 2: Change From Baseline in Serum Iron Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 14 | -3.5 | Standard Deviation 6.66 | Micromoles per liter (umol/L) |
| Periods 1 and 2: Change From Baseline in Serum Iron Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 28 | -2.2 | Standard Deviation 4.79 | Micromoles per liter (umol/L) |
| Periods 1 and 2: Change From Baseline in Serum Iron Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 28 | -3.3 | Standard Deviation 5.01 | Micromoles per liter (umol/L) |
| Period 1 and 2: Change From Baseline in Transferrin Following Treatment With Daprodustat or rhEPO | Daprodustat | Period 1, DAY 14 | 0.182 | Standard Deviation 0.2914 | Gram per Liter (g/L) |
| Period 1 and 2: Change From Baseline in Transferrin Following Treatment With Daprodustat or rhEPO | rhEPO | Period 1, DAY 14 | 0.145 | Standard Deviation 0.2501 | Gram per Liter (g/L) |
| Period 1 and 2: Change From Baseline in Transferrin Following Treatment With Daprodustat or rhEPO | Daprodustat | Period 1, DAY 28 | 0.283 | Standard Deviation 0.2824 | Gram per Liter (g/L) |
| Period 1 and 2: Change From Baseline in Transferrin Following Treatment With Daprodustat or rhEPO | rhEPO | Period 1, DAY 28 | -0.040 | Standard Deviation 0.1756 | Gram per Liter (g/L) |
| Period 1 and 2: Change From Baseline in Transferrin Following Treatment With Daprodustat or rhEPO | Daprodustat | Period 2, DAY 14 | -0.177 | Standard Deviation 0.4664 | Gram per Liter (g/L) |
| Period 1 and 2: Change From Baseline in Transferrin Following Treatment With Daprodustat or rhEPO | rhEPO | Period 2, DAY 14 | -0.163 | Standard Deviation 0.2461 | Gram per Liter (g/L) |
| Period 1 and 2: Change From Baseline in Transferrin Following Treatment With Daprodustat or rhEPO | Daprodustat | Period 2, DAY 28 | 0.138 | Standard Deviation 0.2381 | Gram per Liter (g/L) |
| Period 1 and 2: Change From Baseline in Transferrin Following Treatment With Daprodustat or rhEPO | rhEPO | Period 2, DAY 28 | -0.352 | Standard Deviation 0.2531 | Gram per Liter (g/L) |
| Periods 1 and 2: Change From Baseline in Transferrin Saturation Following Treatment With Daprodustat or rhEPO | Daprodustat | Period 1, DAY 14 | -5.2 | Standard Deviation 13.63 | Percentage (%) of transferrin saturation |
| Periods 1 and 2: Change From Baseline in Transferrin Saturation Following Treatment With Daprodustat or rhEPO | rhEPO | Period 1, DAY 14 | 3.5 | Standard Deviation 12.05 | Percentage (%) of transferrin saturation |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03457701/results